Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Egon Durban is active.

Publication


Featured researches published by Egon Durban.


Journal of Clinical Investigation | 1992

Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).

John D. Reveille; Egon Durban; Miriam J. MacLeod-St Clair; Rose Goldstein; Ramon Moreda; Roy D. Altman; Frank C. Arnett

Previous studies in Caucasians with progressive systemic sclerosis (PSS) have suggested associations of antitopoisomerase I (antitopo I) autoantibodies with either serologically defined HLA-DR2 or DR5. To better define class II HLA associations with the antitopo I response, 161 PSS patients (132 Caucasians and 29 American blacks) were studied for antitopo I autoantibodies by immunodiffusion and immunoblotting, and their HLA-DRB1, DRB3, DQA1, and DQB1 alleles were determined by restriction fragment length polymorphic analysis and DNA oligotyping. Among Caucasians with antitopo I, HLA-DR5(DRB1*1101-*1104), DRB3*0202 and DQw3 (DQw7,8,9) were significantly increased in frequency. In American blacks, however, only HLA-DQB1*0301(DQw7) was significantly increased. The presence of HLA-DQB1*0301(DQw7) and other HLA-DQB1 alleles bearing the uncharged polar amino acid residue tyrosine at position 30 of the outermost domain was found in all antitopo I-positive Caucasian PSS patients compared with 66% of antitopo I-negative PSS patients (pc = 0.007) and 70% of normal controls (pc = 0.008), as well as all antitopo I-positive black patients. The association with HLA-DQB1 was independent of HLA-DR5(DRB1*1101-*1104) or any other HLA-DRB1, DRB3, or DQA1 alleles. Alternative or additional candidate epitopes for this autoimmune response include alanine at position 38 and threonine at position 77 of these same DQB1 alleles. These data suggest that genetic predisposition to the antitopo I response in PSS is associated most closely with the HLA-DQB1 locus.


Biochemical and Biophysical Research Communications | 1983

Phosphorylation of purified Novikoff hepatoma topoisomerase I

Egon Durban; John S. Mills; David Roll; Harris Busch

The purified Novikoff hepatoma nuclear phosphoprotein with a molecular weight of 110 kdalton and pI 8.4, was found to be a type I topoisomerase. When isolated from 32P-labeled Novikoff ascites cells or incubated in vitro with protein kinase, phosphoserine was found to be its major phosphorylated amino acid. The enzymatic activity of topoisomerase I was altered by changes in phosphorylation. Its activity was increased by protein kinase and it was decreased by alkaline phosphatase.


Biochemical and Biophysical Research Communications | 1982

Purification of a protein kinase from human Namalwa cells that phosphorylates topoisomerase I

John S. Mills; Harris Busch; Egon Durban

Abstract A nuclear protein kinase which phosphorylates phosphoprotein 110 8.4 , recently identified as topoisomerase I, has been purified approximately 330 fold from a 10 mM Tris extract of human Namalwa cells. The kinase was chromatographed on DEAE-Sephacel and further purified by affinity chromatography on phosvitin-Sepharose. The protein kinase exhibited a high affinity (Km = 0.3 μM) for topoisomerase I; its affinity for phosvitin was approximately 100 fold lower (Km = 25 μM).


Molecular Immunology | 1991

An antigenic region of topoisomerase I in DNA polymerase chain reaction-generated fragments recognized by autoantibodies of scleroderma patients

Gina Piccinini; Elena Cardellini; Georg Reimer; Frank C. Arnett; Egon Durban

Topoisomerase cDNA and various fragments thereof generated by the DNA polymerase chain reaction were cloned into plasmid expression vectors (pET series) and the expressed polypeptides were probed with scleroderma sera from seven different patients immunoreactive with topoisomerase I. All sera reacted selectively with a region between amino acid residues 405 and 484 of human topoisomerase I. This conclusion is based on loss of reactivity when this region was omitted from larger pieces. Other portions of topoisomerase I were not reactive with these autoantibodies. At least two different epitopes appear to be recognized within this region by different sera based on differences in immunoreactivity of the 405-484 region when expressed as C-terminal, N-terminal or internally within a peptide.


Biochemical and Biophysical Research Communications | 1988

Partial amino acid sequence of rat topoisomerase I: Comparison with the predicted sequences for the human and yeast enzymes

Egon Durban; Massimo Bramucci; Richard G. Cook

The partial amino acid sequence of rat topoisomerase I was determined by gas-phase microsequencing. Seven tryptic peptides closely matched the sequences deduced from human topoisomerase I cDNA (94.5% homology). Similarity to sequences deduced from bakers yeast and fission yeast genomic DNA were restricted to conserved domains which may represent important sites of interaction with DNA or with other proteins.


Arthritis & Rheumatism | 1996

Increased prevalence of systemic sclerosis in a native american tribe in oklahoma. Association with an amerindian HLA haplotype

Frank C. Arnett; Robert F. Howard; Filemon K. Tan; Joann M. Moulds; Wilma B. Bias; Egon Durban; H. Daniel Cameron; Gabe Paxton; Trevor J. Hodge; Paul E. Weathers; John D. Reveille


Arthritis & Rheumatism | 1992

Racial Differences in the Frequencies of Scleroderma‐Related Autoantibodies

John D. Reveille; Egon Durban; Rose Goldstein; Ramon Moreda; Frank C. Arnett


Biochemical Journal | 1998

Nucleolar protein p120 contains an arginine-rich domain that binds to ribosomal RNA

W. C. Gustafson; Charles W. Taylor; B C Valdez; D Henning; A Phippard; Yajun Ren; Harris Busch; Egon Durban


Cancer Research | 1981

Purification and Characterization of a Nuclear DNA-binding Phosphoprotein in Fetal and Tumor Tissues

Egon Durban; David Roll; Gregory Beckner; Harris Busch


Tissue Antigens | 1992

HLA‐DPB1 alleles and autoantibody subsets in systemic lupus erythematosus, Sjögren's syndrome and progressive systemic sclerosis: A question of disease relevance

John D. Reveille; Jett Brady; Miriam Mac Leod‐St Clair; Egon Durban

Collaboration


Dive into the Egon Durban's collaboration.

Top Co-Authors

Avatar

Harris Busch

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Charles W. Taylor

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

David Roll

Roberts Wesleyan College

View shared research outputs
Top Co-Authors

Avatar

John D. Reveille

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Frank C. Arnett

University of Texas Health Science Center at Houston

View shared research outputs
Top Co-Authors

Avatar

Massimo Bramucci

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Benigno C. Valdez

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

John S. Mills

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Richard G. Cook

Baylor College of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge